Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting vs Short-acting G-CSF for FN Prevention in Ovarian Cancer
NCT04101760Phase 3Unknown
- Start
- Oct 2019
- Primary completion
- Oct 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in febrile neutropenia (FN). Status: unknown.
02
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT04101760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04101760.